MXPA04000647A - Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas. - Google Patents

Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.

Info

Publication number
MXPA04000647A
MXPA04000647A MXPA04000647A MXPA04000647A MXPA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A
Authority
MX
Mexico
Prior art keywords
aminolevulinic acid
ulcers
phtosensitizer
photochemotherapy
esters
Prior art date
Application number
MXPA04000647A
Other languages
English (en)
Spanish (es)
Inventor
Klaveness Jo
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of MXPA04000647A publication Critical patent/MXPA04000647A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04000647A 2001-07-26 2002-07-25 Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas. MXPA04000647A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118251.8A GB0118251D0 (en) 2001-07-26 2001-07-26 Method
PCT/GB2002/003386 WO2003011265A2 (en) 2001-07-26 2002-07-25 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds

Publications (1)

Publication Number Publication Date
MXPA04000647A true MXPA04000647A (es) 2004-05-17

Family

ID=9919248

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000647A MXPA04000647A (es) 2001-07-26 2002-07-25 Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.

Country Status (13)

Country Link
US (1) US20040259949A1 (https=)
EP (1) EP1414430A2 (https=)
JP (1) JP2005501050A (https=)
KR (1) KR20040030863A (https=)
CN (1) CN1533271A (https=)
CA (1) CA2454136A1 (https=)
CZ (1) CZ2004257A3 (https=)
GB (1) GB0118251D0 (https=)
HU (1) HUP0401192A3 (https=)
MX (1) MXPA04000647A (https=)
NO (1) NO20040321L (https=)
RU (1) RU2004105655A (https=)
WO (1) WO2003011265A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
US20090264492A1 (en) * 2006-08-29 2009-10-22 Stichting Voor De Technische Wetenschappen Pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
AU2008337067A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
EP2268311A4 (en) * 2008-04-04 2014-08-27 Immunolight Llc NON-INVASIVE SYSTEMS AND IN SITU PHOTOBIOMODULATION METHODS
RU2395315C1 (ru) * 2008-12-01 2010-07-27 Государственное унитарное предприятие г. Москвы Международный научный и клинический центр "Интермедбиофизхим" (ГУП МНКЦ "Интермедбиофизхим") Способ фотодинамической терапии гнойных ран и трофических язв
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
RU2526803C2 (ru) 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
CA2790827A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
WO2012012616A1 (en) * 2010-07-21 2012-01-26 Patty-Fu Giles Photoactive vitamin nanoparticles for the treatment of chronic wounds
CA2819810A1 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
WO2012086802A1 (ja) 2010-12-24 2012-06-28 アークレイ株式会社 癌細胞の検出方法
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
CN103717215B (zh) * 2011-06-16 2016-08-17 思佰益药业股份有限公司 过敏性鼻炎的治疗剂
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2766049A1 (en) 2011-10-14 2014-08-20 Photocure ASA Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
WO2014062839A1 (en) 2012-10-16 2014-04-24 Surmodics, Inc. Wound packing device and methods
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
EP3011972B1 (en) * 2013-06-19 2019-10-23 SBI Pharmaceuticals Co., Ltd. Medicinal composition for promoting synthesis of protoporphyrin ix
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
RU2604399C1 (ru) * 2015-12-01 2016-12-10 Сергей Владимирович Москвин Способ лазерной терапии больных трофическими язвами
RU2661084C1 (ru) * 2017-07-21 2018-07-11 Федеральное Агентство Научных Организаций Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ комплексного лечения пролежней у пациентов с длительной иммобилизацией
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN112062713B (zh) * 2020-08-04 2023-03-31 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds

Also Published As

Publication number Publication date
WO2003011265A3 (en) 2003-04-24
HUP0401192A3 (en) 2005-07-28
WO2003011265A2 (en) 2003-02-13
US20040259949A1 (en) 2004-12-23
GB0118251D0 (en) 2001-09-19
JP2005501050A (ja) 2005-01-13
NO20040321L (no) 2004-03-19
CA2454136A1 (en) 2003-02-13
EP1414430A2 (en) 2004-05-06
CZ2004257A3 (cs) 2004-08-18
RU2004105655A (ru) 2005-04-10
KR20040030863A (ko) 2004-04-09
CN1533271A (zh) 2004-09-29
HUP0401192A2 (hu) 2004-12-28

Similar Documents

Publication Publication Date Title
MXPA04000647A (es) Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.
WO2002064163A3 (en) Reduction or prevention of pdt related inflammation
EP1649853A3 (en) Microtubule stabilizing agents for treating atherosclerosis or restenosis
DE69731652D1 (de) Verfahren zur behandlung von endothelialen verletzungen
NO20060307L (no) Anvendelse av kinoazolinderivatet ZD6474 kombinert med platinaforbindelser og eventuelt ioniserende straling i behandling av sykdommer assosoiert med angiogenese og/eller okt vaskulaert permeabilitet
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
PT784429E (pt) Combinacoes terapeuticas de dilatadores venosos e dilatadores arteriais
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
DE602007008385D1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
WO2001024783A3 (de) Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
IS8186A (is) Meðferð fyrir uppskurð á verkjum eftir uppskurð
WO2001054678A3 (en) Combination therapy for cancer
RU2460555C1 (ru) Способ лечения ожоговых ран
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
DE60126199D1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
DE60232154D1 (de) Prophylaktische und therapeutische verwendung von hydroxysteroiden